Jason David Sawyer - 01 Jul 2026 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Reporting relationship: Director
Issuer ticker: LIXT
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:16:48 UTC
Prior SEC filing: 17 Apr 2026
Next SEC filing: 23 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jason Sawyer

Key filing fact

Jason David Sawyer filed Form 4 for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) on 02 Jul 2026.

Key facts

This page summarizes Jason David Sawyer's Form 4 filing for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 16:16.

Change

Previous filing in this sequence was filed on 17 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002076325 Primary reporting owner

Sawyer Jason David

Relationship: Director
Address: 433 PLAZA REAL.,, SUITE 275, BOCA RATON
Signature: /s/ Jason Sawyer
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIXT transaction

Common Stock

Award

Transaction value
Shares: +40,000
Change %: +160%
Price: $0.000000^*
Shares after: 65,000
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported transaction involved the Reporting Person's receipt of 40,000 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable RSU agreement and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 40,000 RSUs vested upon the achievement of the performance conditions set forth in the Reporting Person's RSU agreement, which have been satisfied.

Footnote F2

The total reported in Column 5 includes (i) the 40,000 newly awarded RSUs, and (ii) 25,000 RSUs, all of which have vested.